Stock Ticker

  • Loading stock data...

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) – Nuvigil Patent Infringement Lawsuit Resolved

Boston, MA 06/20/2014 (wallstreetpr) – Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) continues to file a series of patent infringement lawsuits against various company as it seeks to protect its products from generic competition. It goes without saying that some of these cases result in unnecessary expenses, prompting companies to opt for early settlement as it […]

Competition Stricken Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) May Look For India Deal Despite Denial

Boston, MA 05/23/2014 (wallstreetpr) – The Israel-based drug company Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has taken several doses of its own medicine in recent times. The company that thrives in developing and marketing generic drugs has in recent times until last week tried to stop competitors from developing a copycat of its bestselling Copaxone […]

Q3 Earnings Results Cause Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) Stock To Fall

Boston, MA 11/01/2013 (wallstreetpr) – Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) was negatively impacted with the posting of the third quarter earnings results that failed to meet analysts and investors expectations. The abrupt departure of its Chief Executive Officer Jeremy Levin also continues to disrupt the fortunes of the drug maker. Teva’s Depositary receipts fell by […]